These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22139081)

  • 41. Ensemble clustering of phosphoproteomic data identifies differences in protein interactions and cell-cell junction integrity of HER2-overexpressing cells.
    Schaberg KE; Shirure VS; Worley EA; George SC; Naegle KM
    Integr Biol (Camb); 2017 Jun; 9(6):539-547. PubMed ID: 28492659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Astrocyte-induced Reelin expression drives proliferation of Her2
    Jandial R; Choy C; Levy DM; Chen MY; Ansari KI
    Clin Exp Metastasis; 2017 Feb; 34(2):185-196. PubMed ID: 28210910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.
    Anido J; Matar P; Albanell J; Guzmán M; Rojo F; Arribas J; Averbuch S; Baselga J
    Clin Cancer Res; 2003 Apr; 9(4):1274-83. PubMed ID: 12684395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
    Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer.
    Li Q; Mullins SR; Sloane BF; Mattingly RR
    Neoplasia; 2008 Apr; 10(4):314-29. PubMed ID: 18392133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
    Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells.
    Zhang P; Chen Y; Gong M; Zhuang Z; Wang Y; Mu L; Wang T; Pan J; Liu Y; Xu J; Liang R; Yuan Y
    Cell Physiol Biochem; 2018; 50(1):52-65. PubMed ID: 30326469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.
    Laurin M; Huber J; Pelletier A; Houalla T; Park M; Fukui Y; Haibe-Kains B; Muller WJ; Côté JF
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7434-9. PubMed ID: 23592719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
    Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
    Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fhit expression protects against HER2-driven breast tumor development: unraveling the molecular interconnections.
    Bianchi F; Tagliabue E; Ménard S; Campiglio M
    Cell Cycle; 2007 Mar; 6(6):643-6. PubMed ID: 17374991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells.
    Hindupur SK; Balaji SA; Saxena M; Pandey S; Sravan GS; Heda N; Kumar MV; Mukherjee G; Dey D; Rangarajan A
    Breast Cancer Res; 2014 Aug; 16(4):420. PubMed ID: 25096718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
    Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers.
    Kollara A; Kahn HJ; Marks A; Brown TJ
    Breast Cancer Res Treat; 2001 Jun; 67(3):245-53. PubMed ID: 11561770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.
    Cuadros M; Cano C; López FJ; López-Castro R; Concha A
    Pathobiology; 2013; 80(1):32-40. PubMed ID: 22832278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells.
    Jeon M; Lee J; Nam SJ; Shin I; Lee JE; Kim S
    Exp Cell Res; 2015 Apr; 333(1):116-26. PubMed ID: 25743092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paget's disease of the nipple in a Her2-positive breast cancer xenograft model.
    Drews-Elger K; Sandoval-Leon AC; Ergonul AB; Jegg AM; Gomez-Fernandez C; Miller PC; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2020 Feb; 179(3):577-584. PubMed ID: 31720992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.
    Korkaya H; Paulson A; Iovino F; Wicha MS
    Oncogene; 2008 Oct; 27(47):6120-30. PubMed ID: 18591932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
    Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
    Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.